Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| SCIENTIFIC INDUSTRIES INCSCND · Entity 8003 | Director | February 17, 2026 | March 17, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
SCIENTIFIC INDUSTRIES INC
Report date February 17, 2026 · Filed March 17, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $0.60 · Expires 2036-02-17 | Direct | 96,186 |
Reported balance
After 2026-02-17 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-02-17 · Grant · Acquired 24,000 · Balance 96,186 F1: Options granted to Registrant in lieu of cash fees. Vesting 1 year - 1/12th per month. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $0.60 · Expires 2036-02-17 | Direct | 116,186 |
Reported balance
After 2026-02-17 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-02-17 · Grant · Acquired 20,000 · Balance 116,186 |
Filing footnotes · ownership attribution and instrument terms
F1: Options granted to Registrant in lieu of cash fees. Vesting 1 year - 1/12th per month.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 17, 2026 Filed Mar 17, 2026 19:41 UTC | SCIENTIFIC INDUSTRIES INC SCND · Entity 8003 | GrantStock Option · Derivative | 20,000 | $0.00 Strike: $0.60 | $0.00 |
DisclosureSEC source: 0002021300-26-000001 · primary_doc.xml · derivative · entry 2 BLECHMAN MICHAEL · CIK 0002021300 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 116,186 Underlying: Common Stock · 20,000 shares Expires 2036-02-17 Read SEC document |
| February 17, 2026 Filed Mar 17, 2026 19:41 UTC | SCIENTIFIC INDUSTRIES INC SCND · Entity 8003 | GrantStock Option · Derivative | 24,000 | $0.00 Strike: $0.60 | $0.00 |
DisclosureSEC source: 0002021300-26-000001 · primary_doc.xml · derivative · entry 1 BLECHMAN MICHAEL · CIK 0002021300 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 96,186 Underlying: Common Stock · 24,000 shares Expires 2036-02-17 F1 · derivative.exercise_date: Options granted to Registrant in lieu of cash fees. Vesting 1 year - 1/12th per month. Read SEC document |
| August 20, 2025 Filed Sep 9, 2025 17:07 UTC | SCIENTIFIC INDUSTRIES INC SCND · Entity 8003 | GrantCommon Stock | 10,000 | $1.00 | $10,000.00 |
DisclosureSEC source: 0002021300-25-000003 · primary_doc.xml · nonDerivative · entry 1 BLECHMAN MICHAEL · CIK 0002021300 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,186 F1 · price: On August 20, 2025, 10,000 warrants for 10,000 shares of the Company's Common Stock were exercised at $1.00 per share. Read SEC document |
| April 18, 2025 Filed May 19, 2025 17:34 UTC | SCIENTIFIC INDUSTRIES INC SCND · Entity 8003 | PurchaseWarrants to Purchase Common Stock · Derivative | 10,000 | Not disclosed Strike: $1.00 | Not disclosed |
DisclosureSEC source: 0002021300-25-000002 · primary_doc.xml · derivative · entry 2 BLECHMAN MICHAEL · CIK 0002021300 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,186 Underlying: Common Stock · 10,000 shares Expires 2025-10-18 F1 · price: On April 18, 2025 Registrant purchased from Scientific Industries, Inc. (the "Issuer") for an aggregate purchase price of $10,000, 10,000 shares of Common Stock and warrants to acquire 10,000 shares of Common Stock at an exercise price of $1.00 per share. Read SEC document |
| April 18, 2025 Filed May 19, 2025 17:34 UTC | SCIENTIFIC INDUSTRIES INC SCND · Entity 8003 | PurchaseCommon Stock | 10,000 | $1.00 | $10,000.00 |
DisclosureSEC source: 0002021300-25-000002 · primary_doc.xml · nonDerivative · entry 1 BLECHMAN MICHAEL · CIK 0002021300 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Read SEC document |
| July 01, 2024 Filed Aug 2, 2024 20:38 UTC | SCIENTIFIC INDUSTRIES INC SCND · Entity 8003 | GrantOption to Purchase Common Stock · Derivative | 5,000 | $0.00 Strike: $1.29 | $0.00 |
DisclosureSEC source: 0002021300-24-000003 · primary_doc.xml · derivative · entry 1 BLECHMAN MICHAEL · CIK 0002021300 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,186 Underlying: Common Stock · 5,000 shares Expires 2034-07-01 Read SEC document |
| May 17, 2024 Filed Jun 27, 2024 14:44 UTC | SCIENTIFIC INDUSTRIES INC scnd · Entity 8003 | GrantOptions to Purchase Common Stock · Derivative | 7,186 | Not disclosed Strike: $2.50 | Not disclosed |
DisclosureSEC source: 0002021300-24-000002 · primary_doc.xml · derivative · entry 2 BLECHMAN MICHAEL · CIK 0002021300 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,186 Underlying: Common Stock · 7,186 shares Expires 2034-05-17 F2 · price: On May 17, 2024 the Reporting Person and the Issuer entered into an agreement to elect to be paid part of his fees in lieu of cash compensation. These options vest in twelve monthly installments commencing on May 17, 2024 through May 17, 2025. F2 · derivative.exercise_date: On May 17, 2024 the Reporting Person and the Issuer entered into an agreement to elect to be paid part of his fees in lieu of cash compensation. These options vest in twelve monthly installments commencing on May 17, 2024 through May 17, 2025. Read SEC document |
| May 17, 2024 Filed Jun 27, 2024 14:44 UTC | SCIENTIFIC INDUSTRIES INC scnd · Entity 8003 | GrantOptions to Purchase Common Stock · Derivative | 25,000 | $0.00 Strike: $1.75 | $0.00 |
DisclosureSEC source: 0002021300-24-000002 · primary_doc.xml · derivative · entry 1 BLECHMAN MICHAEL · CIK 0002021300 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2034-05-17 F1 · derivative.exercise_date: Options vest in three successive equal installments from 5/17/24 as to 1/3 on each of the first, second, and third anniversaries. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.